Prostatic Neoplasms: all 6,484 studies

Page 19 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.

• Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate CancerTerminatedNCT02516670Phase 2Results posted
• Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate CancerTerminatedNCT02508636Phase 2Results posted
• Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate CancerTerminatedNCT02506114Phase 2Results posted
• Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate CancerTerminatedNCT02501759Not applicableResults posted
• Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC)TerminatedNCT02500901Phase 1Results posted
• Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate CancerCompletedNCT02499835Phase 1/2Results posted
• A Selective Androgen Receptor Modulator for Symptom Management in Prostate CancerCompletedNCT02499497Phase 2Results posted
• LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPCCompletedNCT02494921Phase 1/2Results posted
• Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate CancerTerminatedNCT02494713Phase 2Results posted
• Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and DocetaxelTerminatedNCT02491411Not applicableResults posted
• Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate CancerCompletedNCT02489357Not applicableResults posted
• A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCActive, not recruitingNCT02489318Phase 3Results posted
• 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate CancerCompletedNCT02488070Phase 1/2Results posted
• A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer VaccineCompletedNCT02485964Not applicableResults posted
• Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted AgentCompletedNCT02485691Phase 4Results posted
• A Study of Pertuzumab in Participants With Prostate CancerTerminatedNCT02480010Phase 2Results posted
• Incorporating MR Imaging Into Prostate Radiotherapy Treatment PlanningCompletedNCT02470910Not applicableResults posted
• Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPCCompletedNCT02463799Phase 2Results posted
• Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate CancerTerminatedNCT02454517Not applicableResults posted
• Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)CompletedNCT02443571Results posted
• A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel TreatmentTerminatedNCT02441517Phase 4Results posted
• 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate CancerCompletedNCT02440308Phase 2Results posted
• Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate CancerCompletedNCT02430480Phase 2Results posted
• Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation TherapyTerminatedNCT02420652Phase 2Results posted
• Impact on Instructional Video on Patients' Compliance With Preparation During CT Planning for Prostate CancerCompletedNCT02410291Not applicableResults posted
• A Study of Enzalutamide and LY3023414 in Men With Prostate CancerCompletedNCT02407054Phase 2Results posted
• 11C- and 18F-Choline PET/MR Imaging for Prostate CancerCompletedNCT02397408Phase 2Results posted
• A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)CompletedNCT02384382Phase 2Results posted
• Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4aCompletedNCT02381015Not applicableResults posted
• Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or EnzalutamideTerminatedNCT02379390Phase 2Results posted
• Metformin for Rising PSA Remote TrialCompletedNCT02376166Not applicableResults posted
• Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139CompletedNCT02362464Phase 2Results posted
• Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate CancerTerminatedNCT02362451Phase 2Results posted
• Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal SpacerCompletedNCT02353832Phase 2Results posted
• Maintaining Suppression of Testosterone With Transdermal Estradiol GelTerminatedNCT02349386Phase 2Results posted
• A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate CancerCompletedNCT02346526Phase 2Results posted
• Focal Prostate Radio-Frequency AblationCompletedNCT02328807Not applicableResults posted
• PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active SurveillanceCompletedNCT02326805Phase 2Results posted
• ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT02325557Phase 1/2Results posted
• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)Active, not recruitingNCT02319837Phase 3Results posted
• Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideActive, not recruitingNCT02312557Phase 2Results posted
• Transurethral Ultrasonic Imaging For Detection and Classification of Prostate CancerTerminatedNCT02307552Not applicableResults posted
• An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer ParticipantsCompletedNCT02294461Phase 3Results posted
• A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide AloneCompletedNCT02288247Phase 3Results posted
• Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide ResistanceCompletedNCT02286921Phase 2Results posted
• Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate CancerCompletedNCT02280356Phase 2Results posted
• Dose Finding Safety Study of VAL201 in Cancer PatientsCompletedNCT02280317Phase 1/2Results posted
• Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy NaiveCompletedNCT02279862Phase 2Results posted
• Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate CancerCompletedNCT02278185Phase 2Results posted
• Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate CancerCompletedNCT02278055Phase 2Results posted
• Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate CancerCompletedNCT02274779Phase 2Results posted
• Enzalutamide/Leuprolide +/- Abiraterone/Pred in ProstateCompletedNCT02268175Phase 2Results posted
• Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate CancerCompletedNCT02260817Phase 3Results posted
• An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)Active, not recruitingNCT02257736Phase 3Results posted
• EXTEND Exercise TrialCompletedNCT02256111Phase 2Results posted
• MRI Based Active Selection for Treatment TrialCompletedNCT02242773Not applicableResults posted
• Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate CarcinomaCompletedNCT02234115Phase 3Results posted
• Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and SurvivorsCompletedNCT02233842Results posted
• Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)CompletedNCT02224482Not applicableResults posted
• Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate CancerCompletedNCT02218606Phase 2Results posted
• Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate CancerCompletedNCT02217709Phase 2Results posted
• Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol TherapyCompletedNCT02217566Phase 2Results posted
• Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate CancerTerminatedNCT02215161Phase 2Results posted
• Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate CancerCompletedNCT02215096Phase 1Results posted
• Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.CompletedNCT02213107Phase 2Results posted
• Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate CancerCompletedNCT02212197Phase 2Results posted
• A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate CancerTerminatedNCT02203513Phase 2Results posted
• Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate CancerCompletedNCT02200614Phase 3Results posted
• Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate CancerCompletedNCT02199197Phase 2Results posted
• 18F-DCFBC PET/CT in Prostate CancerCompletedNCT02190279Early Phase 1Results posted
• Metformin Prostate Cancer Adjuvant TrialCompletedNCT02176161Phase 2Results posted
• Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer PatientsTerminatedNCT02173522Not applicableResults posted
• Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"CompletedNCT02167893Results posted
• Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT02159950Phase 2Results posted
• Prostate Cancer Screening in Men With Germline BRCA2 MutationsCompletedNCT02154672Results posted
• Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical ProstatectomyCompletedNCT02153918Phase 2Results posted
• SHIP (Selinexor in Hormone Insensitive Prostate Cancer)TerminatedNCT02146833Phase 2Results posted
• A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate CancerCompletedNCT02142608Phase 1/2Results posted
• A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate CancerCompletedNCT02141659Phase 1Results posted
• A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate CancerCompletedNCT02135653Results posted
• Radium 223 in Castrate Resistant Prostate Cancer Bone MetastasesCompletedNCT02135484Not applicableResults posted
• Safety and Efficacy of TAK-385 for Patients With Localized Prostate CancerCompletedNCT02135445Phase 2Results posted
• Facilitating Participation in a Prostate Cancer Risk Assessment ProgramCompletedNCT02126319Not applicableResults posted
• A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate CancerCompletedNCT02116582Phase 4Results posted
• A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor BiopsyCompletedNCT02115828Early Phase 1Results posted
• Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerCompletedNCT02111577Phase 3Results posted
• A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate CancerCompletedNCT02111187Phase 1Results posted
• Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide TherapyCompletedNCT02099864Phase 2Results posted
• Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone MetastasisCompletedNCT02097303Phase 2Results posted
• Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active SurveillanceCompletedNCT02095145Phase 2Results posted
• Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) PatientsCompletedNCT02091531Phase 2Results posted
• RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)CompletedNCT02090114Phase 2Results posted
• A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate CancerCompletedNCT02085252Phase 3Results posted
• A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate CancerCompletedNCT02083185Phase 2Results posted
• Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate CancerCompletedNCT02079025Not applicableResults posted
• Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate CancerCompletedNCT02064582Phase 2Results posted
• PET Imaging in MCI Following ADT for PCaCompletedNCT02061345Results posted
• A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate CancerCompletedNCT02059213Phase 2Results posted
• LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate CancerCompletedNCT02058706Phase 2Results posted
• Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)CompletedNCT02057939Phase 2Results posted

← Prostatic Neoplasms overview